News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

News Kommuniqué III

2023 Announcements.Corporate.Newsletter

30.06.2023

Notification of cessation of securities

2023 Announcements . Financial . Regulatory

29.06.2023

Twilight Event – Briefing

2023 Announcements . Corporate . News

29.06.2023

Change of Director’s Interest Notice

2023 Announcements . Financial . Regulatory

28.06.2023

News Communiqué III

2023 Announcements . Corporate . News

26.06.2023

Strategic Update VI

2023 Announcements . Corporate . Presentation

01.06.2023

CLINUVEL Bulletin Edition 01

2023 Announcements . Newsletter

31.05.2023

CLINUVEL escalates PRÉNUMBRA® to moderate/severe stroke patients

2023 Announcements . Clinical . News . Regulatory

09.05.2023

Expansion of CLINUVEL’s global porphyria programs

2023 Announcements . Clinical . Regulatory

01.05.2023

News Kommuniqué II

2023 Announcements . Corporate . Newsletter

11.04.2023

News Communiqué I – Ms Cristina Ramos

2023 Announcements . Newsletter

07.04.2023

News Communiqué II

2023 Announcements . Corporate . News

05.04.2023

Investor Presentation – NYC Nasdaq Event

2023 Announcements . Financial . Regulatory

30.03.2023

.

Go To Top